P. Efentakis

发表

The Natural Olive Constituent Oleuropein Induces Nutritional Cardioprotection in Normal and Cholesterol-Fed Rabbits: Comparison with Preconditioning

I. Andreadou, D. Benaki, P. Efentakis, 2014, Planta Medica.

Vascular conditioning prevents adverse left ventricular remodelling after acute myocardial infarction: a randomised remote conditioning study

M. Gazouli, J. Lekakis, I. Andreadou, 2021, Basic Research in Cardiology.

Elucidating Carfilzomib’s Induced Cardiotoxicity in an In Vivo Model of Aging: Prophylactic Potential of Metformin

M. Dimopoulos, I. Trougakos, I. Andreadou, 2021, International journal of molecular sciences.

Thiol-based redox-active proteins as cardioprotective therapeutic agents in cardiovascular diseases

A. Daiber, I. Andreadou, P. Efentakis, 2021, Basic Research in Cardiology.

Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects

M. Brizzi, N. Kostomitsopoulos, G. Dimitriadis, 2017, Front. Physiol..

Hydroxytyrosol ameliorates metabolic, cardiovascular and liver changes in a rat model of diet‐induced metabolic syndrome: Pharmacological and metabolism‐based investigation

I. Andreadou, P. Efentakis, M. Halabalaki, 2017, Pharmacological research.

Tubulin-folding cofactor E deficiency promotes vascular dysfunction by increased endoplasmic reticulum stress

T. Münzel, P. Efentakis, A. Schulz, 2021, European heart journal.

Effects of the Olive Tree Leaf Constituents on Myocardial Oxidative Damage and Atherosclerosis

N. Dagres, I. Andreadou, P. Efentakis, 2015, Planta Medica.

Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin.

M. Dimopoulos, I. Trougakos, I. Andreadou, 2019, Blood.

Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?

A. Vlahou, N. Kostomitsopoulos, G. Dimitriadis, 2022, Basic Research in Cardiology.

Transient carotid ischemia as a remote conditioning stimulus for myocardial protection in anesthetized rabbits: Insights into intracellular signaling.

I. Andreadou, P. Efentakis, Sofia-Iris Bibli, 2015, International journal of cardiology.

Ranolazine triggers pharmacological preconditioning and postconditioning in anesthetized rabbits through activation of RISK pathway.

N. Dagres, I. Andreadou, P. Efentakis, 2013, European journal of pharmacology.

T Cell-Derived IL-17A Induces Vascular Dysfunction via Perivascular Fibrosis Formation and Dysregulation of ·NO/cGMP Signaling

A. Waisman, T. Münzel, A. Daiber, 2019, Oxidative medicine and cellular longevity.

Association of Hypoglycemia with Biomarkers of Oxidative Stress and Antioxidants: An Observational Study

K. Makrilakis, P. Efentakis, V. Lambadiari, 2022, Healthcare.

Synthesis and Pharmacological Evaluation of Novel Adenine-Hydrogen Sulfide Slow Release Hybrids Designed as Multitarget Cardioprotective Agents.

A. Papapetropoulos, I. Andreadou, P. Efentakis, 2016, Journal of medicinal chemistry.

Electronic Cigarette Smoking Increases Arterial Stiffness and Oxidative Stress to a Lesser Extent Than a Single Conventional Cigarette: An Acute and Chronic Study.

J. Lekakis, I. Andreadou, P. Efentakis, 2018, Circulation.

Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose dependent manner: Implications for inotropy.

N. Kostomitsopoulos, D. Sanoudou, T. Suter, 2020, Cardiovascular research.

Aestivation motifs explain hypertension and muscle mass loss in mice with psoriatic skin barrier defect

M. Rauh, A. Waisman, F. Luft, 2021, Acta physiologica.

Mineralocorticoid Receptor Pathway Is a Key Mediator of Carfilzomib-induced Nephrotoxicity: Preventive Role of Eplerenone

A. Vlahou, N. Kostomitsopoulos, N. Thomaidis, 2022, HemaSphere.

Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib

M. Dimopoulos, I. Andreadou, P. Efentakis, 2020, International journal of molecular sciences.

Chronic Empaglifozin treatment reduces myocardial infarct size in non-diabetic mice through STAT-3 mediated protection on microvascular endothelial cells and reduction of oxidative stress.

A. Vlahou, M. Brizzi, N. Kostomitsopoulos, 2020, Antioxidants & redox signaling.

An Untargeted Metabolomics Approach on Carfilzomib-Induced Nephrotoxicity

N. Thomaidis, I. Andreadou, P. Efentakis, 2022, Molecules.

Saffron (Crocus sativus) intake provides nutritional preconditioning against myocardial ischemia-reperfusion injury in Wild Type and ApoE(-/-) mice: Involvement of Nrf2 activation.

N. Kostomitsopoulos, R. León, I. Andreadou, 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Cardioprotection by H2S Donors: Nitric Oxide-Dependent and ‑Independent Mechanisms

A. Papapetropoulos, M. Whiteman, A. Daiber, 2016, The Journal of Pharmacology and Experimental Therapeutics.

Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost

P. Ferdinandy, F. Triposkiadis, I. Andreadou, 2022, International journal of molecular sciences.

"Pistacia lentiscus L." reduces the infarct size in normal fed anesthetized rabbits and possess antiatheromatic and hypolipidemic activity in cholesterol fed rabbits.

I. Andreadou, P. Efentakis, E. Iliodromitis, 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection

H. Bøtker, Z. Giricz, P. Ferdinandy, 2018, Basic Research in Cardiology.

Targeting myeloid cell coagulation signaling blocks MAP kinase/TGF-β1–driven fibrotic remodeling in ischemic heart failure

S. Tenzer, T. Münzel, A. Daiber, 2022, The Journal of clinical investigation.

Reciprocal regulation of eNOS, H2S and CO-synthesizing enzymes in human atheroma: Correlation with plaque stability and effects of simvastatin

A. Papapetropoulos, I. Andreadou, P. Efentakis, 2017, Redox biology.

Acute administration of the olive constituent, oleuropein, combined with ischemic postconditioning increases myocardial protection by modulating oxidative defense.

N. Kostomitsopoulos, O. Tsitsilonis, A. Papapetropoulos, 2021, Free radical biology & medicine.

Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors.

N. Kostomitsopoulos, A. Tsantili-Kakoulidou, A. Papapetropoulos, 2019, Cardiovascular research.

Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?

A. Vlahou, N. Kostomitsopoulos, G. Dimitriadis, 2022, Basic Research in Cardiology.

Impaired Arterial Elastic Properties and Endothelial Glycocalyx in Patients with Embolic Stroke of Undetermined Source

G. Tsivgoulis, I. Andreadou, P. Efentakis, 2019, Thrombosis and Haemostasis.

Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and Degradation

N. Thomaidis, I. Andreadou, P. Efentakis, 2023, International journal of molecular sciences.

Synergistic Pulmonoprotective Effect of Natural Prolyl Oligopeptidase Inhibitors in In Vitro and In Vivo Models of Acute Respiratory Distress Syndrome

N. Kostomitsopoulos, F. Triposkiadis, I. Andreadou, 2023, International journal of molecular sciences.

Antihypertensive Potential of Pistacia lentiscus var. Chia: Molecular Insights and Therapeutic Implications

N. Kostomitsopoulos, I. Trougakos, P. Efentakis, 2024, Nutrients.

Hydrolytic Activity of Mitochondrial F1FO-ATP Synthase as a Target for Myocardial Ischemia-Reperfusion Injury: Discovery and In Vitro and In Vivo Evaluation of Novel Inhibitors.

G. Lambrinidis, P. Efentakis, E. Mikros, 2023, Journal of medicinal chemistry.

Implications and hidden toxicity of cardiometabolic syndrome and early‐stage heart failure in carfilzomib‐induced cardiotoxicity

P. Efentakis, M. Gavriatopoulou, E. Terpos, 2024, British journal of pharmacology.